Effectiveness and safety of denosumab on osteoporosis treatment in kidney transplant recipients
The use of denosumab in KTRs is effective and safe for the treatment of osteoporosis and prevention of fracture, but it should be carefully monitored for complications, especially UTI.
Authors
- Woo Yeong Park (ORCID: https://orcid.org/0000-0003-2662-2898)
- Yaerim Kim (ORCID: https://orcid.org/0000-0003-1596-1528)
- Jin Hyuk Paek (ORCID: https://orcid.org/0000-0001-8875-1260)
- Seungyeup Han (ORCID: https://orcid.org/0000-0002-7561-6534)
- Kyubok Jin (ORCID: https://orcid.org/0000-0002-7836-8863)
- Jin Kyung Kwon (ORCID: https://orcid.org/0009-0000-3986-0639)
Institutions
- Keimyung University (KR)
Publication Details
- Journal
- Kidney Research and Clinical Practice
- Published
- 2024-11-18
- DOI
- https://doi.org/10.23876/j.krcp.24.168
- Citations
- 1
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- National Research Foundation
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea